CNBC's UK Exchange newsletter: Curtain falls on the era of big UK conglomerates

FTSE-100 engineering firm Smiths Group is undergoing a significant strategic transformation, shedding its conglomerate status through major divestments, including the recent £1.3 billion ($1.74 billion) sale of Smiths Interconnect and a dual-track process for Smiths Detection. This move, driven by CEO Roland Carter to create a more focused entity comprising John Crane and Flex-Tek, has already resulted in a more than 30% surge in Smiths' shares since its announcement. The company's break-up marks a broader trend signaling the decline of the conglomerate model's dominance in corporate Britain, aiming for enhanced investor clarity and valuation.

Analysis

Smiths Group, a FTSE-100 engineering firm, is actively divesting non-core assets to shed its conglomerate structure, a strategic move initiated by CEO Roland Carter. This includes the recent £1.3 billion ($1.74 billion) sale of Smiths Interconnect to Molex and the prior $2.7 billion disposal of Smiths Medical to ICU Medical. A dual-track process is also underway for Smiths Detection, aiming to streamline the company to two core businesses: John Crane and Flex-Tek.

Carter's rationale for the break-up is to enhance investor clarity and unlock value, believing the diversified structure led to market misunderstanding and undervaluation. Since the announcement, Smiths' shares have surged over 30%, reaching record highs, indicating strong investor approval for the focused strategy and anticipating improved performance. This positive revaluation suggests the market is rewarding the company for its strategic simplification.

This divestment strategy signifies a broader trend in corporate Britain, marking the decline of the traditional conglomerate model, contrasting with previous resistance from figures like former chairman George Buckley. The successful execution and positive market response position Smiths as a potential blueprint for other complex industrial holdings seeking re-rating through strategic focus. The move aligns with a market preference for pure-play entities, which are often perceived as easier to understand and value.

Key Decisions for Investors

• Investors should evaluate Smiths Group's re-rating potential, given the over 30% share price increase post-announcement and the positive market reception to its focused strategy.
• Monitor the progress and terms of the Smiths Detection divestment, as its successful completion is crucial for the final streamlined structure and valuation.
• Consider the implications of this successful break-up for other diversified industrial companies in the UK market, as it may signal a broader trend towards pure-play strategies.